Download PDF
Synlett 2002(4): 0613-0615
DOI: 10.1055/s-2002-22724
LETTER
© Georg Thieme Verlag Stuttgart · New York

Synthetic Studies on a Cyclic Hexadepsipeptide GE3: Stereoselective Construction of the Acyl Side Chain Segment

Kazuishi Makino, Yoshiaki Henmi, Yasumasa Hamada*
Graduate School of Pharmaceutical Sciences, Chiba University, Yayoi-cho, Inage-ku, Chiba 263-8522, Japan
Fax: +81(43)2902987; e-Mail: hamada@p.chiba-u.ac.jp;
Further Information

Publication History

Received 10 December 2001
Publication Date:
05 February 2007 (online)

    Permissions and Reprints All articles of this category

Abstract

Stereoselective synthesis of the acyl side chain segment 2 of GE3 (1), a potent inhibitor of cell progression of the cell cycle from the G1 to S phase, has been achieved by using Sharpless’ asymmetric dihydroxylation and Evans’ and Paterson’s stereoselective aldol methodologies.

Key words

GE3 - hexadepsipeptide - asymmetric dihydroxylation - asymmetric aldol reaction - antitumor activity

    References

  • 1a Sakai Y. Yoshida T. Tsujita T. Ochiai K. Agatsuma T. Saitoh Y. Tanaka F. Akiyama T. Akinaga S. Mizukami T. J. Antibiot.  1997,  50:  659 
    Google Scholar
  • 1b Agatsuma T. Sakai Y. Mizukami T. Saitoh Y. J. Antibiot.  1997,  50:  704 
    Google Scholar
  • 1c Yoshida T. Sakai Y. Mizukami T. Nippon Kagaku Kaishi  1997,  71:  516 
    Google Scholar
  • 2 Hayakawa Y. Nakagawa M. Toda Y. Seto H. Agric. Biol. Chem.  1990,  54:  1007 
    Google Scholar
  • 3 Maehr H. Liu C. Palleroni NJ. Smallheer J. Todaro L. Williams TH. Blount JF. J. Antibiot.  1986,  39:  17 
    Google Scholar
  • 4 Smitka TA. Deeter JB. Hunt AH. Mertz FP. Ellis RM. Boeck LD. Yao RC. J. Antibiot.  1988,  41:  726 
    CrossrefGoogle Scholar
  • 5 Nakagawa M. Hayakawa Y. Adachi K. Seto H. Agric. Biol. Chem.  1990,  54:  791 
    Google Scholar
  • 6 Hensens OD. Borris RP. Koupal LR. Caldwell CG. Currie SA. Haidri AA. Homnick CF. Honeycutt SS. Lindermayer SM. Schwartz CD. Weissberger BA. Woodruff HB. Zink DL. Zitano L. Fieldhouse JM. Rollins T. Springer MS. Springer JP. J. Antibiot.  1991,  44:  249 
    Google Scholar
  • 7 Nishiyama Y. Sugawara K. Tomita K. Yamamoto H. Kamei H. Oki T. J. Antibiot.  1993,  46:  921 
    CrossrefGoogle Scholar
  • 8 Ueno M. Amemiya M. Someno T. Matsuda T. Iinuma H. Nakagawa H. Hamada M. Ishizuka M. Takeuchi T. J. Antibiot.  1993,  46:  1658 
    Google Scholar
  • 9 Gräfe U. Ritzau SM. Ihn W. Dornberger K. Stengel C. Freck WF. Gutsche W. Härtl A. Paulus EF. J. Antibiot.  1995,  48:  119 
    Google Scholar
  • 10a Umezawa K. Nakazawa K. Uemura T. Ikeda Y. Kondo S. Naganawa H. Kinoshita N. Hashizume H. Hamada M. Takeuchi T. Ohba S. Tetrahedron Lett.  1998,  39:  1389 
    CrossrefGoogle Scholar
  • 10b Umezawa K. Nakazawa K. Ikeda Y. Naganawa H. Kondo S. J. Org. Chem.  1999,  64:  3034 
    CrossrefGoogle Scholar
  • See for the previous synthetic studies on the acyl side chain of A83586C similar to the structure of GE3:
  • 12a Hale KJ. Bhatia GS. Peak SA. Manaviazar S. Tetrahedron Lett.  1993,  34:  5343 
    CrossrefGoogle Scholar
  • 12b Hale KJ. Cai J. Manaviazar S. Peak SA. Tetrahedron Lett.  1995,  36:  6965 
    CrossrefGoogle Scholar
  • 12c Hale KJ. Cai J. Tetrahedron Lett.  1996,  37:  4233 
    CrossrefGoogle Scholar
  • 13a Sharpless KB. Amberg W. Bennani YL. Crispino GA. Hartung J. Jeong K.-S. Kwong H.-L. Morikawa K. Wang Z.-M. Xu D. Zhang X.-L. J. Org. Chem.  1992,  57:  2768 
    Google Scholar
  • 13b Kolb HC. Van Nieuwenhze MS. Sharpless KB. Chem. Rev.  1994,  94:  2483 
    Google Scholar
  • 14a Evans DA. Bartoli J. Shih TL. J. Am. Chem. Soc.  1981,  103:  2127 
    Google Scholar
  • 14b Gage JR. Evans DA. Org. Synth.  1989,  68:  77 
    Google Scholar
  • 14c Gage JR. Evans DA. Org. Synth.  1989,  68:  83 
    Google Scholar
  • 15 Paterson I. Wallace DJ. Velazquez SM. Tetrahedron Lett.  1994,  35:  9083 
    CrossrefGoogle Scholar
  • 17 Evans DA. Rieger DL. Bilodeau MT. Urpi F. J. Am. Chem. Soc.  1991,  113:  1047 
    CrossrefGoogle Scholar
  • 18 Fukuyama T. Lin S.-C. Li L. J. Am. Chem. Soc.  1990,  112:  7050 
    CrossrefGoogle Scholar
  • 19 Hamada Y. Shibata M. Sugiura T. Kato S. Shioiri T. J. Org. Chem.  1987,  52:  1252 
    CrossrefGoogle Scholar
  • 20 House HO. Crumrine DS. Teranishi AY. Olmstead HD. J. Am. Chem. Soc.  1973,  95:  3310 
    CrossrefGoogle Scholar
  • 21a Atkins GM. Burgess EM. J. Am. Chem. Soc.  1968,  90:  4744 
    CrossrefGoogle Scholar
  • 21b Burgess EM. Penton HR. Taylor EA. J. Am. Chem. Soc.  1970,  92:  5224 
    CrossrefGoogle Scholar
  • 21c Burgess EM. Penton HR. Taylor EA. J. Org. Chem.  1973,  38:  26 
    CrossrefGoogle Scholar
  • 22a Mahoney WS. Bretensky DM. Stryker JM. J. Am. Chem. Soc.  1988,  110:  291 
    CrossrefGoogle Scholar
  • 22b Mahoney WS. Stryker JM. J. Am. Chem. Soc.  1989,  111:  8818 
    CrossrefGoogle Scholar
  • 22c Bretensky DM. Stryker JM. Tetrahedron Lett.  1989,  30:  5677 
    CrossrefGoogle Scholar
11

The structure of GE3, including the absolute configuration, was deduced to be as shown in Scheme [1] by Sakai and coworkers.

16

The minor enantiomer of 4 was removed after the coupling with enantiomerically pure C5-C14 fragment 5.

23

Compound 2: [α]D 23 +20.5 (c 0.19, CHCl3); IR(neat): 3474, 2956, 2857, 1722, 1462, 1254 cm-1; 1H NMR (500 MHz, C6D6): δ = 0.70 (d, J = 6.7 Hz, 3 H, C6-CH 3 ), 1.01 (d, J = 6.8 Hz, 3 H, C10-CH 3 ), 1.30-1.45 (m, 1 H, C6-H), 1.50-1.60 (m, 13 H, C2-CH 3 , C5-H, C8-CH 3 , C12-CH 3 , C14-H), 1.65-1.80 (m, 2 H, C5-H, C4-H), 2.04 (dd, J = 12.8, 10.3 Hz, C4-H), 2.64 (m, 1 H, C10-H), 3.25 (brs, 1 H, OH), 3.71 (d, J = 6.7 Hz, 1 H, C11-H), 4.01 (d, J = 10.4 Hz, 1 H, C7-H), 4.45 (s, 1 H, OH), 5.01 (d, J = 12.2 Hz, 1 H, ArCH 2 ), 5.09 (d, J = 12.2 Hz, 1 H, ArCH 2), 5.30 (d, J = 9.4 Hz, 1 H, C9-H), 5.37 (m, 1 H, C13-H), 7.10-7.20 (m, 5 H, Ar-H); 13C NMR (125 MHz, C6D6): δ = 11.8, 12.1, 13.0, 16.5, 17.8, 20.0, 27.4, 27.7, 32.3, 36.3, 67.5, 79.4, 81.2, 83.4, 99.7, 120.5, 128.4, 128.6, 128.8, 132.2, 133.1, 135.7, 137.8, 176.0.